Day RO - Search Results

1

Giving and receiving of gifts between pharmaceutical companies and medical specialists in Australia.

McNeill PM, Kerridge IH, Henry DA, Stokes B, Hill SR, Newby D, Macdonald GJ, Day RO, Maguire J, Henderson KM. McNeill PM, et al. Among authors: day ro. Intern Med J. 2006 Sep;36(9):571-8. doi: 10.1111/j.1445-5994.2006.01151.x. Intern Med J. 2006. PMID: 16911549

2

Non-steroidal anti-inflammatory drug induced upper gastrointestinal haemorrhage and bleeding.

Day RO, Henry DA, Muirden KD, Yeomans ND, Brooks PM, Stiel D, Prichard PJ. Day RO, et al. Med J Aust. 1992 Dec 7-21;157(11-12):810-2. doi: 10.5694/j.1326-5377.1992.tb141295.x. Med J Aust. 1992. PMID: 1454016 Review. No abstract available.

3

Pattern of non-steroidal anti-inflammatory drug use in Australia 1990-1994. A report from the Drug Utilization Sub-Committee of the Pharmaceutical Benefits Advisory Committee.

McManus P, Primrose JG, Henry DA, Birkett DJ, Lindner J, Day RO. McManus P, et al. Among authors: day ro. Med J Aust. 1996 May 20;164(10):589-92. Med J Aust. 1996. PMID: 8637461

4

Access to medicines and high-quality therapeutics: global responsibilities for clinical pharmacology.

Day RO, Birkett DJ, Miners J, Shenfield GM, Henry DA, Seale JP. Day RO, et al. Med J Aust. 2005 Apr 4;182(7):322-3. doi: 10.5694/j.1326-5377.2005.tb06728.x. Med J Aust. 2005. PMID: 15804221

5

Cooperative partnerships or conflict-of-interest? A national survey of interaction between the pharmaceutical industry and medical organizations.

Kerridge I, Maguire J, Newby D, McNeill PM, Henry D, Hill S, Day R, Macdonald G, Stokes B, Henderson K. Kerridge I, et al. Intern Med J. 2005 Apr;35(4):206-10. doi: 10.1111/j.1444-0903.2004.00799.x. Intern Med J. 2005. PMID: 15836497

6

Medical specialists and pharmaceutical industry-sponsored research: a survey of the Australian experience.

Henry DA, Kerridge IH, Hill SR, McNeill PM, Doran E, Newby DA, Henderson KM, Maguire J, Stokes BJ, Macdonald GJ, Day RO. Henry DA, et al. Among authors: day ro. Med J Aust. 2005 Jun 6;182(11):557-60. doi: 10.5694/j.1326-5377.2005.tb06813.x. Med J Aust. 2005. PMID: 15938681

7

Access to tumour necrosis factor inhibitors for rheumatoid arthritis treatment under the Australian Pharmaceutical Benefits Scheme: are we on target?

Lu CY, Williams KM, Day RO. Lu CY, et al. Among authors: day ro. Intern Med J. 2006 Jan;36(1):19-27. doi: 10.1111/j.1445-5994.2005.00992.x. Intern Med J. 2006. PMID: 16409309

8

Evaluating medicines: let's use all the evidence.

Kelman CW, Pearson SA, Day RO, Holman CD, Kliewer EV, Henry DA. Kelman CW, et al. Among authors: day ro. Med J Aust. 2007 Mar 5;186(5):249-52. doi: 10.5694/j.1326-5377.2007.tb00883.x. Med J Aust. 2007. PMID: 17391088 Review.

9

Has the use of disease-modifying anti-rheumatic drugs changed as a consequence of controlled access to high-cost biological agents through the Pharmaceutical Benefits Scheme?

Lu CY, Williams KM, Day RO. Lu CY, et al. Among authors: day ro. Intern Med J. 2007 Sep;37(9):601-6. doi: 10.1111/j.1445-5994.2007.01396.x. Epub 2007 Jun 2. Intern Med J. 2007. PMID: 17542999

10

Patterns of analgesic and anti-inflammatory medicine use by Australian veterans.

Pearson SA, Ringland C, Kelman C, Mant A, Lowinger J, Stark H, Nichol G, Day R, Henry D. Pearson SA, et al. Intern Med J. 2007 Dec;37(12):798-805. doi: 10.1111/j.1445-5994.2007.01516.x. Intern Med J. 2007. PMID: 18028081

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

465 results

Search Page

Filters